SCHEMBL1509679

SCHEMBL1509679

[CH]=Cc1ccccc1CC

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.41
GABRB2 P47870 4/20 0.41
MGLL Q99685 1/20 0.38
CHAT P28329 1/20 0.37
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36
THRB P10828 1/20 0.36
BLM P54132 1/20 0.36
KMT2A Q03164 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
MAPT P10636 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP24A1 Q07973 1/20 0.35
TP53 P04637 1/20 0.35
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
MAOA P21397 1/20 0.34
MITF O75030 1/20 0.34
CCR3 P51677 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11371115 0.82 MITF (0.40) ALDH1A1MITFCYP2D6
SCHEMBL14565080 0.81 GABRA1 (0.41) GABRA1GABRB2MGLLCHATMEN1
SCHEMBL6546259 0.80 CHAT (0.47) GABRA1GABRB2MGLLCHATMEN1
SCHEMBL3314625 0.80 CHAT (0.47) GABRA1GABRB2MGLLCHATMEN1
SCHEMBL1283641 0.80 GABRA1 (0.44) GABRA1GABRB2MGLLCHATMEN1
SCHEMBL3864511 0.79 TSHR (0.46) MEN1LMNATHRBBLMKMT2A
SCHEMBL22401086 0.79 CYP3A4 (0.47) THRBMITFCYP2D6
SCHEMBL29897321 0.78 LMNA (0.57) GABRA1GABRB2MGLLMEN1LMNA
SCHEMBL18242067 0.78 GABRA1 (0.42) GABRA1GABRB2MGLLCHATMEN1
SCHEMBL2915753 0.78 GABRA1 (0.42) GABRA1GABRB2MGLLCHATMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2295592-B1 An enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin NIPPON CATALYTIC CHEM IND (JP) 2012-12-26 EP disclosed
EP-1160329-B1 An enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin NIPPON CATALYTIC CHEM IND (JP) 2011-04-06 EP disclosed
EP-2295592-A1 An enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin Nippon Shokubai Co., Ltd. (JP) 2011-03-16 EP disclosed
EP-1160235-B1 A method for producing alpha-hydroxycarboxylic acid NIPPON CATALYTIC CHEM IND (JP) 2006-09-20 EP disclosed
US-7078225-B2 Method for enzymatically producing an optically active cyanohydrin NIPPON SHOKUBAI CO., LTD. (JP) 2006-07-18 US disclosed
EP-1043021-B1 PURINE DERIVATIVES FOR THE TREATMENT OF ALLERGIC DISEASES AND SYSTEMIC LUPUS ERYTHEMATOSUS DAINIPPON SUMITOMO PHARMA CO (JP) 2006-05-03 EP disclosed
EP-0882727-B9 NOVEL PURINE DERIVATIVES SUMITOMO PHARMA (JP) 2005-06-15 EP disclosed
EP-1527135-A1 FLUORINATED POLYMERS 3M Innovative Properties Company (US) 2005-05-04 EP disclosed
US-20050089977-A1 Enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin NIPPON SHOKUBAI CO., LTD. 2005-04-28 US disclosed
US-6864389-B2 Method for producing α-hydroxycarboxylic acid NIPPON SHOKUBAI CO., LTD. (JP) 2005-03-08 US disclosed
US-6376501-B1 INHIBITING OR REGULATING IMMUNE RESPONSE USING PURINE-DERIVED COMPOUND; NON-STEROIDAL COMPOUND JAPAN ENERGY CORPORATION (JP) 2002-04-23 US disclosed
US-20020006646-A1 Enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin NIPPON SHOKUBAI CO., LTD. 2002-01-17 US disclosed
EP-1160329-A2 An enzyme reaction method and a method for enzymatically producing an optically active cyanohydrin Nippon Shokubai Co., Ltd. (JP) 2001-12-05 EP disclosed
EP-1160235-A2 A method for producing alpha-hydroxycarboxylic acid Nippon Shokubai Co., Ltd. (JP) 2001-12-05 EP disclosed
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-1043021-A1 TYPE 2 HELPER T CELL-SELECTIVE IMMUNE RESPONSE SUPPRESSORS Japan Energy Corporation (JP) 2000-10-11 EP disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed
US-6028076-A FOR INDUCING .ALPHA.-INTERFERON IN A PATIENT HAVING HEPATITIS B OR C, BY ADMINISTERING PURINE DERIVATIVE JAPAN ENERGY CORPORATION (JP) 2000-02-22 US disclosed
EP-0882727-A1 NOVEL PURINE DERIVATIVES JAPAN ENERGY CORPORATION (JP) 1998-12-09 EP disclosed
EP-0549222-A2 Siloxy-functional cyclopolysiloxanes DOW CORNING CORPORATION (US) 1993-06-30 EP disclosed